๐”– Scriptorium
โœฆ   LIBER   โœฆ

๐Ÿ“

Fragment-Based Drug Discovery and X-Ray Crystallography

โœ Scribed by Daniel A. Erlanson (auth.), Thomas G. Davies, Marko Hyvรถnen (eds.)


Publisher
Springer-Verlag Berlin Heidelberg
Year
2012
Tongue
English
Leaves
234
Series
Topics in Current Chemistry 317
Edition
1
Category
Library

โฌ‡  Acquire This Volume

No coin nor oath required. For personal study only.

โœฆ Synopsis


Introduction to Fragment-Based Drug Discovery, by Daniel A. Erlanson

Fragment Screening Using X-Ray Crystallography, by Thomas G. Davies and Ian J. Tickle

Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening, by Stephen Roughley, Lisa Wright, Paul Brough, Andrew Massey and Roderick E. Hubbard

Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors, by Daniel F. Wyss, Yu-Sen Wang, Hugh L. Eaton, Corey Strickland, Johannes H. Voigt, Zhaoning Zhu and Andrew W. Stamford

Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery, by Michael Hennig, Armin Ruf and Walter Huber

Targeting Proteinโ€“Protein Interactions and Fragment-Based Drug Discovery, by Eugene Valkov, Tim Sharpe, May Marsh, Sandra Greive and Marko Hyvรถnen

Fragment Screening and HIV Therapeutics, by Joseph D. Bauman, Disha Patel and Eddy Arnold

Fragment-Based Approaches and Computer-Aided Drug Discovery, by Didier Rognan

โœฆ Table of Contents


Front Matter....Pages i-xi
Introduction to Fragment-Based Drug Discovery....Pages 1-32
Fragment Screening Using X-Ray Crystallography....Pages 33-59
Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening....Pages 61-82
Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors....Pages 83-114
Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery....Pages 115-143
Targeting Proteinโ€“Protein Interactions and Fragment-Based Drug Discovery....Pages 145-179
Fragment Screening and HIV Therapeutics....Pages 181-200
Fragment-Based Approaches and Computer-Aided Drug Discovery....Pages 201-222
Back Matter....Pages 223-225

โœฆ Subjects


Organic Chemistry; Crystallography; Pharmaceutical Sciences/Technology


๐Ÿ“œ SIMILAR VOLUMES


Fragment-Based Drug Discovery and X-Ray
โœ Daniel A. Erlanson (auth.), Thomas G. Davies, Marko Hyvรถnen (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 2012 ๐Ÿ› Springer-Verlag Berlin Heidelberg ๐ŸŒ English

<p><p>Introduction to Fragment-Based Drug Discovery, by Daniel A. Erlanson </p><p>Fragment Screening Using X-Ray Crystallography, by Thomas G. Davies and Ian J. Tickle</p><p>Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening, by Stephen Roughley, Lisa Wright, Paul Brough, Andrew Massey a

Fragment-Based Drug Discovery and X-Ray
โœ Daniel A. Erlanson (auth.), Thomas G. Davies, Marko Hyvรถnen (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 2012 ๐Ÿ› Springer-Verlag Berlin Heidelberg ๐ŸŒ English

<p><p>Introduction to Fragment-Based Drug Discovery, by Daniel A. Erlanson </p><p>Fragment Screening Using X-Ray Crystallography, by Thomas G. Davies and Ian J. Tickle</p><p>Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening, by Stephen Roughley, Lisa Wright, Paul Brough, Andrew Massey a

Fragment-Based Drug Discovery
โœ Steven Howard, Chris Abell (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 2015 ๐Ÿ› Royal Society of Chemistry ๐ŸŒ English

<P>Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is

Fragment-Based Drug Discovery
โœ Steven Howard, Chris Abell (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 2015 ๐Ÿ› Royal Society of Chemistry ๐ŸŒ English

<P>Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is

Fragment-based Drug Discovery: Lessons a
โœ Daniel A. Erlanson, Wolfgang Jahnke (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 2016 ๐Ÿ› Wiley-VCH ๐ŸŒ English

<p>From its origins as a niche technique more than 15 years ago, fragment-based approaches have become a major tool for drug and ligand discovery, often yielding results where other methods have failed. Written by the pioneers in the field, this book provides a comprehensive overview of current meth